In vivo imaging of spinal cord atrophy in neuroinflammatory diseases

Annals of Neurology

Volumn 76, Issue 3, 2014, Pages 370-378

  Liu, Winston ^a,b   Nair, Govind ^a   Vuolo, Luisa ^a   Bakshi, Anshika ^a,c   Massoud, Raya ^a   Reich, Daniel S ^a   Jacobson, Steven ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CERVICAL SPINAL CORD; CERVICAL SPINE; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CARRIER; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; EXPANDED DISABILITY STATUS SCALE; FEMALE; HAUSER AMBULATION INDEX; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IN VIVO STUDY; MALE; MOBILIZATION; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RISK FACTOR; SCRIPPS NEUROLOGIC RATING SCORE; SPINAL CORD; SPINAL CORD ATROPHY; SPINAL CORD CROSS SECTIONAL AREA; THORACOLUMBAR SPINE; TROPICAL SPASTIC PARAPARESIS; VERTEBRA BODY; VIRUS LOAD; ATROPHY; COMPARATIVE STUDY; DEVICES; DISABILITY; HETEROZYGOTE; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LUMBAR VERTEBRA; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERTEBRA; VIROLOGY;

ADULT; ATROPHY; CARRIER STATE; CERVICAL VERTEBRAE; DISABILITY EVALUATION; FEMALE; HTLV-I INFECTIONS; HUMANS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARAPARESIS, TROPICAL SPASTIC; SPINAL CORD; THORACIC VERTEBRAE; VIRAL LOAD;

EID: 84907878924     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24213     Document Type: Article

References (31)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-7419.
2. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058-6068.
3. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1993;52:424-430.
4. Aye MM, Matsuoka E, Moritoyo T, et al. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol 2000;100:245-252.
5. Bagnato F, Butman JA, Mora CA, et al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol 2005;11:525-534.
6. Kermode AG, Rudge P, Thompson AJ, et al. MRI of thoracic cord in tropical spastic paraparesis. J Neurol Neurosurg Psychiatry 1990;53:1110-1111.
7. Melo A, Moura L, Rios S, et al. Magnetic resonance imaging in HTLV-I associated myelopathy. Arq Neuropsiquiatr 1993;51:329-332.
8. Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125(pt 8):1676-1695.
9. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119(pt 3):701-708.
10. Lin X, Tench CR, Turner B, et al. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003;74:1090-1094.
11. Horsfield MA, Filippi M. Spinal cord atrophy and disability in multiple sclerosis over four years. J Neurol Neurosurg Psychiatry 2003;74:1014-1015.
12. Milagres AC, Jorge ML, Marchiori PE, Segurado AA. Human T cell lymphotropic virus type 1-associated myelopathy in Sao Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort. Neuroepidemiology 2002;21:153-158.
13. Alcindor F, Valderrama R, Canavaggio M, et al. Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies. Neuroradiology 1992;35:69-74.
14. Horsfield MA, Sala S, Neema M, et al. Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage 2010;50:446-455.
15. Evangelou IE, Massoud R, Jacobson S. HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images. J Neuroimaging 2014;24:74-78.
16. Oh J, Zackowski K, Chen M, et al. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis. Mult Scler 2013;19:427-435.
17. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637.
18. Sigmund EE, Suero GA, Hu C, et al. High-resolution human cervical spinal cord imaging at 7 T. NMR Biomed 2012;25:891-899.
19. Kearney H, Yiannakas MC, Abdel-Aziz K, et al. Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J Magn Reson Imaging 2014;39:617-623.
20. Nair G, Absinta M, Reich DS. Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3T. AJNR Am J Neuroradiol 2013;34:2215-2222.
21. Bakshi R, Thompson AJ, Rocca MA, et al. MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7:615-625.
22. Chen M, Carass A, Oh J, et al. Automatic magnetic resonance spinal cord segmentation with topology constraints for variable fields of view. Neuroimage 2013;83:1051-1062.
23. Canny J. A computational approach to edge detection. IEEE Trans Pattern Anal Mach Intell 1986;8:679-698.
24. Ferraz AC, Gabbai AA, Abdala N, Nogueira RG. Magnetic resonance in HTL-I associated myelopathy. Leukoencephalopathy and spinal cord atrophy [in Portuguese]. Arq Neuropsiquiatr 1997;55:728-736.
25. Yukitake M, Takase Y, Nanri Y, et al. Incidence and clinical significances of human T-cell lymphotropic virus type I-associated myelopathy with T2 hyperintensity on spinal magnetic resonance images. Intern Med 2008;47:1881-1886.
26. Lin X, Tench CR, Evangelou N, et al. Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging 2004;14(3 suppl):20S-26S.
27. Klein JP, Arora A, Neema M, et al. A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol 2011;32:1138-1142.
28. Rocca MA, Horsfield MA, Sala S, et al. A multicenter assessment of cervical cord atrophy among MS clinical phenotypes. Neurology 2011;76:2096-2102.
29. Valsasina P, Rocca MA, Horsfield MA, et al. Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis. Radiology 2013;266:853-861.
30. Sena A, Pedrosa R, Ferret-Sena V, et al. Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis. Mult Scler 2008;14:857-859.
31. Olavarria VN, Gomes Ado N, Kruschewsky Rde A, et al. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil. Braz J Infect Dis 2012;16:357-360.